Search Results - MCKINLEY, Arin

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

    Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants by Smith, Bryan D., Kaufman, Michael D., Lu, Wei-Ping, Gupta, Anu, Leary, Cynthia B., Wise, Scott C., Rutkoski, Thomas J., Ahn, Yu Mi, Al-Ani, Gada, Bulfer, Stacie L., Caldwell, Timothy M., Chun, Lawrence, Ensinger, Carol L., Hood, Molly M., McKinley, Arin, Patt, William C., Ruiz-Soto, Rodrigo, Su, Ying, Telikepalli, Hanumaiah, Town, Ajia, Turner, Benjamin A., Vogeti, Lakshminarayana, Vogeti, Subha, Yates, Karen, Janku, Filip, Abdul Razak, Albiruni Ryan, Rosen, Oliver, Heinrich, Michael C., Flynn, Daniel L.

    Published in Cancer cell
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

    Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours by Serrano, César, Mariño-Enríquez, Adrián, Tao, Derrick L., Ketzer, Julia, Eilers, Grant, Zhu, Meijun, Yu, Channing, Mannan, Aristotle M., Rubin, Brian P., Demetri, George D., Raut, Chandrajit P., Presnell, Ajia, McKinley, Arin, Heinrich, Michael C., Czaplinski, Jeffrey T., Sicinska, Ewa, Bauer, Sebastian, George, Suzanne, Fletcher, Jonathan A.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

    Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases by Heinrich, Michael C, Joensuu, Heikki, Demetri, George D, Corless, Christopher L, Apperley, Jane, Fletcher, Jonathan A, Soulieres, Denis, Dirnhofer, Stephan, Harlow, Amy, Town, Ajia, McKinley, Arin, Supple, Shane G, Seymour, John, Di Scala, Lilla, van Oosterom, Allan, Herrmann, Richard, Nikolova, Zariana, McArthur, And Grant

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

    Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours by Serrano, César, Mariño-Enríquez, Adrián, Tao, Derrick L., Ketzer, Julia, Eilers, Grant, Zhu, Meijun, Yu, Channing, Mannan, Aristotle M., Rubin, Brian P., Demetri, George D., Raut, Chandrajit P., Presnell, Ajia, McKinley, Arin, Heinrich, Michael C., Czaplinski, Jeffrey T., Sicinska, Ewa, Bauer, Sebastian, George, Suzanne, Fletcher, Jonathan A.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

    Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors by HEINRICH, Michael C, GRIFFITH, Diana, MCKINLEY, Arin, PATTERSON, Janice, PRESNELL, Ajia, RAMACHANDRAN, Abhijit, DEBIEC-RYCHTER, Maria

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors

    Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors by Heinrich, Michael C, Marino-Enriquez, Adrian, Presnell, Ajia, Donsky, Rachel S, Griffith, Diana J, McKinley, Arin, Patterson, Janice, Taguchi, Takahiro, Liang, Cher-Wei, Fletcher, Jonathan A

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Combination Therapy In Mast Cell Neoplasms: Co-Targeting KIT and NFAT Signaling Pathways

    Combination Therapy In Mast Cell Neoplasms: Co-Targeting KIT and NFAT Signaling Pathways by Macleod, Alison, Patterson, Janice, Beadling, Carol, Griffith, Diana, Town, Ajia, McKinley, Arin, Heinrich, Michael C.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract 3586: CP-868,596, a highly potent PDGFR inhibitor, inhibits phosphorylation of the imatinib-resistant PDGFRA D842V activating mutation associated with advanced GIST

    Abstract 3586: CP-868,596, a highly potent PDGFR inhibitor, inhibits phosphorylation of the imatinib-resistant PDGFRA D842V activating mutation associated with advanced GIST by Heinrich, Michael, Griffith, Diana, McKinley, Arin, Presnell, Ajia, Ramachandran, Abhijit, Chaudhary, Neha

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: